Interview with OrganiGram CEO Denis Arsenault

420 Investor interviewed OrganiGram CEO Denis Arsenault. The company, which began trading on the TSX Venture exchange on 8/25 (OGI), has a U.S. ticker as well: OGRMF. The interview covered the Canadian MMJ market, OrganiGram's differentiation from its peers, why the company is listing on the OTCQB in the U.S., the patient acquisition strategy, near-term operating metrics, potential capital raises and the possibility of being a consolidator.

For more information on OrganiGram:

Posted to Benzinga PotProfits on Aug 27, 2014 — 3:08 PM
Comments on this post have been disabled by the Maven.